Lace(lomustine, ARA-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity

被引：0
|
作者：
Orchard, K
Lyttelton, MP
Abrahamson, G
Stem, S
Abboudi, Z
McGuigan, D
Giles, C
Kanfer, EJ
Samson, D
机构：
[1] CHARING CROSS HOSP,LONDON,ENGLAND
[2] HAMMERSMITH HOSP,LONDON,ENGLAND
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：969 / 969
页数：1
相关论文
共 50 条
  • [1] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity.
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stern, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 174 - 174
  • [2] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal toxicity.
    Orchard, K
    Giles, C
    Apperley, J
    Goldman, JM
    Kanfer, EJ
    Samson, D
    [J]. BLOOD, 1997, 90 (10) : 1855 - 1855
  • [3] REGIMEN-RELATED TOXICITY OF A BUSULFAN-CYCLOPHOSPHAMIDE CONDITIONING REGIMEN IN 70 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEVILL, TJ
    BARNETT, MJ
    KLINGEMANN, HG
    REECE, DE
    SHEPHERD, JD
    PHILLIPS, GL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1224 - 1232
  • [4] Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen
    Grisariu, S.
    Shapira, M. Y.
    Or, R.
    Avni, B.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S441 - S441
  • [5] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [6] Long-term outcome after LACE (lomustine, ara-C, cyclophosphamide, etoposide) conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma
    Perz, JB
    Giles, C
    Szydlo, RM
    Wagner, S
    Sanz, J
    Chaidos, A
    Apperley, JF
    MacDonald, D
    Kanfer, E
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [7] Comparison between BEAM and lomustine, Ara-C, etoposide and melphalan as conditioning regimen before stem cell transplantation. A single-centre experience
    Grillo, G.
    Marenco, P.
    Bertani, G.
    Zucchetti, E.
    Turrini, M.
    Brasca, P.
    Gabutti, C.
    Morra, E.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S194 - S195
  • [8] EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CRILLEY, P
    TOPOLSKY, D
    STYLER, MJ
    BERNSTEIN, E
    RESNICK, K
    MULLANEY, R
    BULOVA, S
    BRODSKY, I
    MARKS, DI
    [J]. BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 361 - 365
  • [9] Preliminary results of fludarabine, idarubicine and ARA-C as conditioning regimen for allogeneic stem cell transplantation.
    Lerner, D
    Pigneux, A
    Agape, P
    Lounici, A
    Fabéres, C
    Marit, G
    Cony-Makhoul, P
    Dazey, B
    Cousin, T
    Reiffers, J
    Boiron, JM
    [J]. BLOOD, 1998, 92 (10) : 352B - 352B
  • [10] Allogeneic bone marrow transplantation for multiple myeloma (MM) using BVAC (BCNU, etoposide, ARA-C, cyclophosphamide) and TBI as preparative regimen.
    deMagalhaes-Silverman, M
    Hohl, RJ
    Lee, CK
    Davis, C
    Scott, S
    Gingrich, RD
    [J]. BLOOD, 1998, 92 (10) : 322B - 322B
12345